Access cutting-edge triple negative breast cancer treatment through this clinical trial at a research site in Oakland. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Oakland location
Access triple negative breast cancer specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related triple negative breast cancer treatment provided free
Check if you qualify for this triple negative breast cancer clinical trial in Oakland, CA
No-Cost Study Care
Local to Oakland
Convenient for CA residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
This is a randomized, open-label study comparing the efficacy and safety of adjuvant sacituzumab tirumotecan (MK-2870) in combination with pembrolizumab compared to treatment of physician's choice (TPC) in participants with triple-negative breast cancer (TNBC) who received neoadjuvant therapy and did not achieve a pathological complete response (pCR) at surgery. The primary objective is to compare sacituzumab tirumotecan plus pembrolizumab to TPC (pembrolizumab or pembrolizumab plus capecitabine
Sponsor: Merck Sharp & Dohme LLC
Yes, this clinical trial (NCT06393374) has an active research site in Oakland, CA that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for triple negative breast cancer treatment options in Oakland, CA, this clinical trial (NCT06393374) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Oakland research site is actively enrolling participants for this clinical trial. You'll receive care from experienced triple negative breast cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all triple negative breast cancer clinical trials near you to find additional studies recruiting in your area.
See all breast cancer clinical trials recruiting in Oakland — not just this study.
Browse Breast Cancer Trials in Oakland →